NCT07224776 2026-02-27Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated ProteinuriaBrigham and Women's HospitalPhase 1 Not yet recruiting20 enrolled
NCT07358520 2026-01-22Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer PatientsFudan UniversityPhase 4 Not yet recruiting40 enrolled